Live from the NIH registry
Studies recruiting near Santa Cruz right now
Top 25 of 174 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: NRG Oncology
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Stanford Cancer Center South Bay — San Jose, California (26.1 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Kaiser Permanente Santa Clara Medical Center — Santa Clara, California (26.3 mi)
· Sponsor: Pfizer
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
San Jose Gastroenterology — San Jose, California (26.1 mi)
· Sponsor: Ardelyx
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Geographic Atrophy Secondary to Age-related Macular Degeneration
N/A
Observational 75 participants sought
Northern California Retina Vitreous Associates Medical Group — Mountain View, California (28.3 mi)
· Sponsor: Complement Therapeutics
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 550 participants sought
Neurocrine Clinical Site — San Jose, California (26.1 mi)
· Sponsor: Neurocrine Biosciences
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Mature B-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 65 participants sought
Kaiser Permanente - Santa Clara — Santa Clara, California (26.3 mi)
· Sponsor: Hoffmann-La Roche
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — San Jose, California (26.1 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Immunoglobulin G4 Related Disease
Phase 3
Interventional 124 participants sought
San Jose Clinical Trials- Site Number : 8400016 — San Jose, California (26.1 mi)
· Sponsor: Sanofi
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Pneumonia, Urinary Tract Infections
N/A
Interventional 2,674 participants sought
Packard at El Camino Hospital — Mountain View, California (28.3 mi)
· Sponsor: University of Utah
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — San Jose, California (26.1 mi)
· Sponsor: Akero Therapeutics, Inc
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12064 — San Jose, California (26.1 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Telenutrition for Individuals With SCI
Spinal Cord Injuries, Obesity
N/A
Interventional 96 participants sought
Santa Clara Valley Medical Center — San Jose, California (26.1 mi)
· Sponsor: Santa Clara Valley Health & Hospital System
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California (26.9 mi)
· Sponsor: NRG Oncology
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Salinas, California (29.5 mi)
· Sponsor: Medtronic
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Satellite Healthcare — San Jose, California (26.1 mi)
· Sponsor: CSL Behring
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Alpha-Thalassemia, Beta-Thalassemia
N/A
Observational 1,000 participants sought
xCures — Los Altos, California (28.4 mi)
· Sponsor: xCures
Quadriceps Strengthening ACL Reconstruction
ACL Tear
N/A
Interventional 20 participants sought
Stanford Medicine Children's Health — Sunnyvale, California (26.9 mi)
· Sponsor: Stanford University
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
PTSD, Post Traumatic Stress Disorder PTSD
N/A
Interventional 40 participants sought
Acacia Research Center — Sunnyvale, California (26.9 mi)
· Sponsor: Acacia Clinics
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US104 — Sunnyvale, California (26.9 mi)
· Sponsor: Incyte Corporation
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3
Interventional 480 participants sought
Retinal Diagnostic Center — Campbell, California (21.8 mi)
· Sponsor: 4D Molecular Therapeutics